您好,欢迎访问新疆农业科学院 机构知识库!

Draft genome sequence of broad-spectrum antifungal-producing Bacillus velezensis C4341 isolated from a saline-alkali soil sample in China

文献类型: 外文期刊

作者: Zhu, Liying 1 ; Liu, Nian 2 ; Wang, Haoqi 3 ; Zhang, Zhidong 4 ; Jiang, Ling 2 ; Huang, He 5 ;

作者机构: 1.Nanjing Tech Univ, Coll Chem & Mol Engn, Nanjing 210009, Peoples R China

2.Nanjing Tech Univ, Coll Food Sci & Light Ind, Nanjing 210009, Peoples R China

3.Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing 210009, Peoples R China

4.Xinjiang Acad Agr Sci, Inst Microbiol, Urumqi, Xinjiang Uygur, Peoples R China

5.Nanjing Tech Univ, Coll Pharmaceut Sci, Nanjing 210009, Peoples R China

关键词: Bacillus velezensis; Whole-genome sequencing; Antagonistic activity; Secondary metabolites; Multidrug resistance

期刊名称:JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE ( 影响因子:4.6; 五年影响因子:4.1 )

ISSN: 2213-7165

年卷期: 2019 年 16 卷

页码:

收录情况: SCI

摘要: Objectives: Bacterial micro-organisms from the genus Bacillus have a broad spectrum of antimicrobial activity against plant pathogenic bacteria, fungi and viruses. Bacillus velezensis has been extensively used as a biocontrol agent in the agricultural field. In the present study, B. velezensis strain C4341 was isolated from saline-alkali soil in Xinjiang, China, producing a wide range of antifungal compounds of different structures. Methods: The whole genome of B. velezensis C4341 was sequenced using an Illumina HiSeq (TM) 2000 sequencing system, was assembled using SOAPdenovo and was optimised with GapCloser. Results: The genome size of strain C4341 was calculated at 3 963 750 bp with a G+C content of 46.4%. The whole genome was assembled into 4019 open reading frames (ORFs), of which 5.9% and 1.6% were related to antagonistic secondary metabolites and antimicrobial resistance, respectively. Conclusion: The whole genome sequence of B. velezensis C4341 will be beneficial in comparative analysis of the genus Bacillus and shows future prospects in antifungal application for sustainable agriculture. (C) 2019 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.

  • 相关文献
作者其他论文 更多>>